Upside | ||||||
|---|---|---|---|---|---|---|
| CRWV | 4.59% | aa.aa | 116.12 | -6.33% | 36,861 | |
| DAVE | 3.67% | aa.aa | 217.16 | +3.90% | 13,563 | |
| AGX | 3.63% | aa.aa | 209.69 | -0.39% | 13,881 | |
| LRN | 3.51% | aa.aa | 151.69 | -1.11% | 16,153 | |
| HIMS | 3.44% | aa.aa | 53.34 | -0.04% | 40,684 | |
| CLS | 3.41% | aa.aa | 163.51 | -0.44% | 21,918 | |
| ROOT | 3.35% | aa.aa | 128.60 | -2.87% | 17,610 | |
| DUOL | 3.33% | aa.aa | 524.40 | -0.11% | 4,597 | |
| PLTR | 3.31% | aa.aa | 123.76 | +0.30% | 19,100 | |
| MRX | 3.19% | aa.aa | 44.54 | -3.40% | 51,698 |
Innovator ETFs Trust - Innovator IBD 50 ETF is an exchange traded fund launched and managed by Innovator Capital Management, LLC. It is co-managed by Penserra Capital Management, LLC. The fund invests in public equity markets of the United States. The fund invests in stocks of companies operating across diversified sectors. The fund invests in growth stocks of companies across diversified market capitalization. The fund seeks to track the performance of the IBD 50 Index, by using full replication technique. Innovator ETFs Trust - Innovator IBD 50 ETF was formed on April 8, 2015 and is domiciled in the United States.